BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14960252)

  • 1. [Circulating DNA, telomerase of circulating tumor cells and early diagnosis of tumors].
    Zhang Z; Yuan Y
    Ai Zheng; 2004 Feb; 23(2):227-9. PubMed ID: 14960252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C; Hu L; Xia L; Li Y
    Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of the breast.
    Ikeda S; Shibata T; Funakoshi N
    Rinsho Byori; 2005 Jun; 53(6):487-93. PubMed ID: 16026073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease.
    Terrin L; Rampazzo E; Pucciarelli S; Agostini M; Bertorelle R; Esposito G; DelBianco P; Nitti D; De Rossi A
    Clin Cancer Res; 2008 Nov; 14(22):7444-51. PubMed ID: 19010861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating hTERT DNA in early breast cancer.
    Divella R; Tommasi S; Lacalamita R; Daniele A; Abbate I; Garrisi VM; Savino E; Coviello M; Rubini V; Simone G; Paradiso A; Quaranta M
    Anticancer Res; 2009 Jul; 29(7):2845-9. PubMed ID: 19596972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic developments involving cell-free (circulating) nucleic acids.
    Tong YK; Lo YM
    Clin Chim Acta; 2006 Jan; 363(1-2):187-96. PubMed ID: 16126188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
    Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
    J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
    Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
    Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
    Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
    Xie XY; Yang X; Zhang JH; Liu ZJ
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
    Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
    Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
    Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
    Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
    Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
    Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of telomerase activity by the TRAP assay and its variants and alternatives.
    Fajkus J
    Clin Chim Acta; 2006 Sep; 371(1-2):25-31. PubMed ID: 16616059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
    J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery and hematogenous dissemination: comparison between the detection of circulating tumor cells and of tumor DNA in plasma before and after tumor resection in rats.
    García-Olmo DC; Gutiérrez-González L; Samos J; Picazo MG; Atiénzar M; García-Olmo D
    Ann Surg Oncol; 2006 Aug; 13(8):1136-44. PubMed ID: 16865589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.